| Catalogue number: | PA 22 0241007 |
| Chemical name: | Methyl ((S)-2-((2S,4S)-2-(4-(2-((2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidin-2-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl)-1H-imidazol-2-yl)-4-(methoxymethyl)pyrrolidin-1-yl)-2-oxo-1-phenylethyl)carbamate |
CAS Number: |
1493768-22-1 |
| Category: | impurities,pharmaceutical standards,intermediates,Fine Chemicals |
| Synonyms: | Carbamic acid, N-[(1S)-2-[(2S,4S)-2-[5-[1,11-dihydro-2-[(2S,5S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-5-methyl-2-pyrrolidinyl][2]benzopyrano[4′,3′:6,7]naphth[1,2-d]imidazol-9-yl]-1H-imidazol-2-yl]-4-(methoxymethyl)-1-pyrrolidinyl]-2-oxo-1-phenylethyl]-, methyl ester; |
| Molecular form: | C49H54N8O8 |
| Appearance: | NA |
| Mol. Weight: | 883.02 |
| Storage: | 2-8°C Refrigerator |
| Shipping Conditions: | Ambient |
| Applications: | epi-Velpatasvir is an impurity of antivaral drug Velpatasvir (V116000), which is a HCV NS5A inhibitor used to treat Hepatitis C. |
Methyl ((S)-2-((2S,4S)-2-(4-(2-((2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidin-2-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl)-1H-imidazol-2-yl)-4-(methoxymethyl)pyrrolidin-1-yl)-2-oxo-1-phenylethyl)carbamate
In House ImpurityMethyl ((S)-2-((2S,4S)-2-(4-(2-((2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidin-2-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl)-1H-imidazol-2-yl)-4-(methoxymethyl)pyrrolidin-1-yl)-2-oxo-1-phenylethyl)carbamate
Enquire for Methyl ((S)-2-((2S,4S)-2-(4-(2-((2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidin-2-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl)-1H-imidazol-2-yl)-4-(methoxymethyl)pyrrolidin-1-yl)-2-oxo-1-phenylethyl)carbamate
Order Product
Related Products
EVENTS
Search by Keywords – Buy 1493768-22-1 | Purchase 1493768-22-1 | Order 1493768-22-1 | Enquire 1493768-22-1 | Price of 1493768-22-1 | 1493768-22-1 Cost | 1493768-22-1 Supplier | 1493768-22-1 Distributor | 1493768-22-1 Manufacturer | 1493768-22-1 Exporter
